Setting

Europe In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity

Published: 31 Aug 2022 | Report Code: 10248759 | Pages: 138

Europe in vitro diagnostics (IVD) market was valued at $ 21,682.6 million in 2021 and will grow by 6.5% annually over 2021-2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing. Highlighted with 35 tables and 64 figures, this 138-page report “Europe In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country. Based on Product, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Instruments & Devices o Disposable IVD Devices o Reusable IVD Devices • Reagents & Kits • Software & Services Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Clinical Chemistry • Molecular Diagnostics • Immuno Diagnostics • Hematology • Tissue Diagnostics • Microbiology • Coagulation and Hemostasis • Urinalysis • Other Technologies By Sample Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Blood • Mucus • Urine • Other Sample Types By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Infectious Diseases • Diabetes • Cancer/Oncology • Cardiology • Autoimmune Disease • Nephrology • Drug Testing • HIV/AIDS • Other Applications By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Diagnostic Laboratories • Hospitals and Clinics • Homecare Settings • Point-of-Care (POC) Settings • Other End Users Geographically, the following national/local markets are fully investigated: • Germany • UK • France • Spain • Italy • Netherlands • Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Abbott Laboratories, Inc. Agilent Technologies, Inc. Arkray Inc. Becton, Dickinson and Company Biomerieux SA Bio-Rad Laboratories Inc. Danaher Corporation DiaSorin SpA (Luminex Corporation) Epic Systems Corporation F. Hoffmann-La Roche Ltd. Genpact Limited Grifols SA IBM Corporation Mckesson Corporation Ortho Clinical Diagnostics Inc. Qiagen NV Quest Diagnostics Inc. Quidel Corporation Roche Diagnostics Siemens Healthineers Sysmex Corporation Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table of Contents:
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of Europe Market by Product 43
3.1 Market Overview by Product 43
3.2 Instruments & Devices 45
3.2.1 Disposable IVD Devices 46
3.2.2 Reusable IVD Devices 47
3.3 Reagents & Kits 48
3.4 Software & Services 49
4 Segmentation of Europe Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Clinical Chemistry 52
4.3 Molecular Diagnostics 53
4.4 Immuno Diagnostics 54
4.5 Hematology 55
4.6 Tissue Diagnostics 56
4.7 Microbiology 57
4.8 Coagulation and Hemostasis 58
4.9 Urinalysis 59
4.10 Other Technologies 60
5 Segmentation of Europe Market by Sample Type 61
5.1 Market Overview by Sample Type 61
5.2 Blood 63
5.3 Mucus 64
5.4 Urine 65
5.5 Other Sample Types 66
6 Segmentation of Europe Market by Application 67
6.1 Market Overview by Application 67
6.2 Infectious Diseases 69
6.3 Diabetes 79
6.4 Cancer/Oncology 80
6.5 Cardiology 81
6.6 Autoimmune Disease 82
6.7 Nephrology 83
6.8 Drug Testing 84
6.9 HIV/AIDS 85
6.10 Other Applications 86
7 Segmentation of Europe Market by End User 87
7.1 Market Overview by End User 87
7.2 Diagnostic Laboratories 89
7.3 Hospitals and Clinics 90
7.4 Homecare Settings 91
7.5 Point-of-Care (POC) Settings 92
7.6 Other End Users 93
8 European Market 2021-2031 by Country 94
8.1 Overview of European Market 94
8.2 Germany 97
8.3 U.K. 99
8.4 France 101
8.5 Spain 103
8.6 Italy 105
8.7 Netherlands 107
8.8 Rest of European Market 109
9 Competitive Landscape 111
9.1 Overview of Key Vendors 111
9.2 New Product Launch, Partnership, Investment, and M&A 114
9.3 Company Profiles 115
Abbott Laboratories, Inc. 115
Agilent Technologies, Inc. 117
Arkray Inc. 118
Becton, Dickinson and Company 119
Biomerieux SA 120
Bio-Rad Laboratories Inc. 121
Danaher Corporation 122
DiaSorin SpA (Luminex Corporation) 123
Epic Systems Corporation 124
F. Hoffmann-La Roche Ltd. 125
Genpact Limited 126
Grifols SA 127
IBM Corporation 128
Mckesson Corporation 129
Ortho Clinical Diagnostics Inc. 130
Qiagen NV 131
Quest Diagnostics Inc. 132
Quidel Corporation 133
Roche Diagnostics 134
Siemens Healthineers 135
Sysmex Corporation 136
Thermo Fisher Scientific Inc. 137
RELATED REPORTS 138
List of Tables:

Table 1.  Snapshot of Europe In Vitro Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5.  Main Product Trends and Market Opportunities in Europe In Vitro Diagnostics Market 35
Table 6. Europe In Vitro Diagnostics Market by Product, 2021-2031, $ mn 43
Table 7. Europe In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn 45
Table 8. Europe In Vitro Diagnostics Market by Technology, 2021-2031, $ mn 50
Table 9. Europe In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn 61
Table 10. Europe In Vitro Diagnostics Market by Application, 2021-2031, $ mn 67
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-2022 70
Table 12. Europe In Vitro Diagnostics Market by End User, 2021-2031, $ mn 87
Table 13. Europe In Vitro Diagnostics Market by Country, 2021-2031, $ mn 96
Table 14. Germany In Vitro Diagnostics Market by Product, 2021-2031, $ mn 98
Table 15. Germany In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 98
Table 16. Germany In Vitro Diagnostics Market by End User, 2021-2031, $ mn 98
Table 17. U.K. In Vitro Diagnostics Market by Product, 2021-2031, $ mn 100
Table 18. U.K. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 100
Table 19. U.K. In Vitro Diagnostics Market by End User, 2021-2031, $ mn 100
Table 20. France In Vitro Diagnostics Market by Product, 2021-2031, $ mn 102
Table 21. France In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 102
Table 22. France In Vitro Diagnostics Market by End User, 2021-2031, $ mn 102
Table 23. Spain In Vitro Diagnostics Market by Product, 2021-2031, $ mn 104
Table 24. Spain In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 104
Table 25. Spain In Vitro Diagnostics Market by End User, 2021-2031, $ mn 104
Table 26. Italy In Vitro Diagnostics Market by Product, 2021-2031, $ mn 106
Table 27. Italy In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 106
Table 28. Italy In Vitro Diagnostics Market by End User, 2021-2031, $ mn 106
Table 29. Netherlands In Vitro Diagnostics Market by Product, 2021-2031, $ mn 108
Table 30. Netherlands In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 108
Table 31. Netherlands In Vitro Diagnostics Market by End User, 2021-2031, $ mn 108
Table 32. In Vitro Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn 110
Table 33. Abbott Laboratories, Inc.: Company Snapshot 115
Table 34. Abbott Laboratories, Inc.: Business Segmentation 116
Table 35. Abbott Laboratories, Inc.: Product Portfolio 116
List of Figures:

Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. Europe In Vitro Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Europe In Vitro Diagnostics Market 26
Figure 7.  Leading Causes of Death in the World, 2000 and 2019, million 29
Figure 8.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of Europe In Vitro Diagnostics Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porter’s Fiver Forces Analysis of Europe In Vitro Diagnostics Market 39
Figure 13. Breakdown of Europe In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue 44
Figure 14. Europe Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 44
Figure 15. Europe In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn 45
Figure 16. Europe In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn 46
Figure 17. Europe In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn 47
Figure 18. Europe In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn 48
Figure 19. Europe In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 49
Figure 20. Breakdown of Europe In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 21. Europe Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 22. Europe In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn 52
Figure 23. Europe In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn 53
Figure 24. Europe In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn 54
Figure 25. Europe In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn 55
Figure 26. Europe In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn 56
Figure 27. Europe In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn 57
Figure 28. Europe In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn 58
Figure 29. Europe In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn 59
Figure 30. Europe In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn 60
Figure 31. Breakdown of Europe In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue 62
Figure 32. Europe Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 62
Figure 33. Europe In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn 63
Figure 34. Europe In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn 64
Figure 35. Europe In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn 65
Figure 36. Europe In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn 66
Figure 37. Breakdown of Europe In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue 68
Figure 38. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 68
Figure 39. Europe In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn 69
Figure 40. Europe In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn 79
Figure 41. Europe In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn 80
Figure 42. Europe In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn 81
Figure 43. Europe In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn 82
Figure 44. Europe In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn 83
Figure 45. Europe In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn 84
Figure 46. Europe In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn 85
Figure 47. Europe In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 86
Figure 48. Breakdown of Europe In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue 88
Figure 49. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 88
Figure 50. Europe In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 89
Figure 51. Europe In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn 90
Figure 52. Europe In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn 91
Figure 53. Europe In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn 92
Figure 54. Europe In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 93
Figure 55. Breakdown of European In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 95
Figure 56. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 96
Figure 57.  In Vitro Diagnostics Market in Germany, 2021-2031, $ mn 97
Figure 58.  In Vitro Diagnostics Market in U.K., 2021-2031, $ mn 99
Figure 59.  In Vitro Diagnostics Market in France, 2021-2031, $ mn 101
Figure 60.  In Vitro Diagnostics Market in Spain, 2021-2031, $ mn 103
Figure 61.  In Vitro Diagnostics Market in Italy, 2021-2031, $ mn 105
Figure 62.  In Vitro Diagnostics Market in Netherlands, 2021-2031, $ mn 107
Figure 63.  In Vitro Diagnostics Market in Rest of Europe, 2021-2031, $ mn 109
Figure 64. Growth Stage of Europe In Vitro Diagnostics Industry over the Forecast Period 111
Selected Key Players: 
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)